MALLORY GROSSMAN: Open Payments
NPI 1982082293 · GOSHEN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$846 in 45 payments from 18 companies in 2025. Trend: 2023 $35 · 2024 $334 · 2025 $846
Food & beverage: $828Education: $19
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. | 10 | $138 |
| Abbott Laboratories | 4 | $86 |
| Radius Health, Inc. | 5 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $84 |
| Lilly USA, LLC | 4 | $66 |
| CeQur Corporation | 1 | $50 |
| Sequel Med Tech, LLC | 2 | $47 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $36 |
| Novo Nordisk Inc | 2 | $34 |
Products named: t:slim X2 Insulin Pump with Control-IQ, JARDIANCE, FREESTYLE LIBRE 3, CeQur Simplicity, TWIIST, ISTURISA, MOUNJARO, TZIELD.
Industry payments across IN — which companies pay providers there.
